Explore how batch variability impacts bioequivalence standards. Learn why the 80-125% rule may be flawed and how new Between-Batch methods improve generic drug safety.
Jan, 14 2026
Mar, 22 2025
Oct, 12 2025
Dec, 22 2025
Dec, 12 2025